Resection of residual masses alone: An alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy

Urology

Volumn 57, Issue 2, 2001, Pages 323-327

  Özen, Haluk ^a   Ekici, Sinan ^a   Sözen, Sinan ^a   Ergen, Ali ^a   Tekgül, Serdar ^a   Kendi, Sezer ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ARTICLE; CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EJACULATION; GERM CELL TUMOR; HISTOLOGY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROPERITONEUM; RETROSPECTIVE STUDY; SEMINOMA; SURGICAL TECHNIQUE; TESTIS CANCER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; EJACULATION; FIBROSIS; GERMINOMA; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECROSIS; POSTOPERATIVE COMPLICATIONS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TESTICULAR NEOPLASMS; THORACIC NEOPLASMS;

EID: 0035129669     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00909-2     Document Type: Article

References (17)

1. Postchemotherapeutic surgery for metastatic testicular germ cell tumors; results of extended primary chemotherapy and limited surgery
2. CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors; can residual malignancy or teratoma be excluded?
3. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer
4. Resection of residual retroperitoneal masses in testicular cancer; evaluation and improvement of selection criteria
5. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
6. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients
7. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours
8. Para-aortic lymphadenectomy after chemotherapy for metastatic nonseminomatous germ cell tumours; prognostic value and therapeutic benefit
9. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses; is a modified dissection and resection of residual masses sufficient?
10. Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma
11. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer
12. Residual mass after chemotherapy for seminoma
13. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors
14. Does necrosis on frozen-section analysis of a mass after chemotherapy justify a limited retroperitoneal resection in patients with advanced testis cancer?
15. Therapeutic guidelines and results in advanced seminoma
16. Residual mass; an indication for further therapy in patients with advanced seminoma following systemic chemotherapy
17. Outcome analysis for germ cell tumor in postchemotherapy retroperitoneal lymph node dissections